Researchers used the Premier Healthcare Database to identify hospitalized patients with infections due to four CR gram-negative bacteria species:
● Acinetobacter baumannii
● Pseudomonas aeruginosa
● Klebsiella pneumoniae
● Escherichia coli
From 2009 to 2013, 4.5 percent (13,262) of 292,742 infections due to the aforementioned gram-negative pathogens were carbapenem-resistant.
Of these CR infections, 82.3 percent were caused by A. baumannii (22 percent) or P. aeruginosa (60.3 percent). K. pneumoniae or E. coli caused 17.7 percent.
The crude all cause in-hospital mortality was greater for most of the CR cohorts compared with the carbapenem-susceptible cohort, especially for A. baumannii infection in blood.
More articles on quality:
Children’s Hospital Colorado to launch 25 clinical trials in next 6 months
Keck Medicine of USC names 1st chief patient safety officer
26% of readmissions are medication related, study shows
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
